Catalyst Overview
Today’s landscape presents 99 total delayed 9M signals with 25 fresh catalyst events, indicating robust episodic pivot activity across multiple sectors. The quality remains high with several candidates showing significant gap moves and institutional neglect patterns. Notably, zero EP-tagged stocks are in play today, suggesting we’re in a fresh wave of catalyst formation rather than follow-through phase.
Of the delayed signals, approximately 70% qualify as potential MAGNA53 candidates based on gap criteria (G flag), with healthcare and financial sectors dominating the landscape. Fresh catalyst events include strong moves in AAOI (+5.4%), AXTI (+6.9%), and CORZ (+7.0%), all generating substantial volume spikes.
Top 5 MAGNA53 Candidates
MGNX ($3.34) — Healthcare
Yesterday’s massive 45.3% catalyst with 14M+ volume created a powerful BullishPinBar setup. Currently testing between strong demand at $2.25-$2.36 and distant supply near $4.92-$5.77. The stock meets both G(gap>=4%) and N(neglect<100) criteria with only 82 institutional funds, creating excellent MAGNA53 qualification.
| Level | Price | Notes |
|---|---|---|
| Entry | $3.40-$3.50 | Above pin bar high |
| Stop | $2.95 | Below demand zone |
| Target 1 | $4.25 | Weekly supply approach |
| Target 2 | $4.90 | Major supply zone |
HIMS ($25.88) — Medical
Strong continuation today (+10.3%) following yesterday’s 5.9% catalyst on massive 118M volume. The BullishMarkupBar shows institutional accumulation with 2.6x relative volume. Gap flag qualified with 595 institutional funds showing broader acceptance despite 63% off 52-week highs.
| Level | Price | Notes |
|---|---|---|
| Entry | $26.00-$26.50 | Current momentum |
| Stop | $24.00 | Daily demand upper |
| Target 1 | $29.00 | Weekly supply lower |
| Target 2 | $31.00 | Supply zone center |
ZVRA ($10.41) — Medical
Yesterday’s 21.3% catalyst created a BullishPinBar with today’s -5.9% pullback offering entry opportunity. The 3.5x relative volume spike confirms institutional interest. Currently positioned between $8.07-$8.95 demand and $10.99-$11.33 supply zones, with G flag qualification.
| Level | Price | Notes |
|---|---|---|
| Entry | $10.50-$10.80 | Pin bar support |
| Stop | $8.95 | Demand zone upper |
| Target 1 | $11.15 | Supply zone test |
| Target 2 | $12.50 | Extension target |
KLAR ($16.43) — Finance
Financial sector momentum continues with +7.4% follow-through on yesterday’s 6.0% catalyst. BullishMarkupBar pattern with gap qualification shows institutional interest in the fintech space. Trading between $14.12-$15.30 demand and $18.11-$21.72 weekly supply provides clear structure.
| Level | Price | Notes |
|---|---|---|
| Entry | $16.50-$17.00 | Markup continuation |
| Stop | $15.30 | Daily demand upper |
| Target 1 | $18.50 | Weekly supply test |
| Target 2 | $20.00 | Supply zone center |
AAOI ($127.01) — Telecom
Telecom infrastructure play with yesterday’s 8.9% catalyst and today’s +5.4% continuation. BullishMarkupBar near 52-week highs (-1.5%) with 301 institutional funds. The momentum pattern suggests sector rotation into infrastructure themes.
| Level | Price | Notes |
|---|---|---|
| Entry | $128.00-$130.00 | Breakout above highs |
| Stop | $119.30 | ATR-based risk |
| Target 1 | $135.00 | Extension target |
| Target 2 | $142.00 | Measured move |
Fresh 9M Catalysts
Today’s fresh catalyst events show strong breadth across sectors. CRWV leads with +9.4% on 33.7M volume, while CORZ and AXTI both show 7%+ moves with substantial volume. BP‘s +4.1% move on 16.4M volume suggests energy sector participation. These fresh catalysts are likely to generate delayed 9M signals in coming sessions, particularly if they form proper episodic pivot patterns.
Summary
The episodic pivot landscape shows exceptional quality today with healthcare dominating the MAGNA53 candidates through gap moves and institutional neglect patterns. The combination of 99 delayed signals and 25 fresh catalysts indicates sustained momentum across multiple sectors. Financial and telecom sectors are emerging as secondary themes, while the absence of EP-tagged stocks suggests we’re in early-stage catalyst formation rather than mature pivot phases. Risk management remains critical given elevated ATR levels across most candidates.